Hospira Misled Investors To Pump Up Stock Prices: Suit
IUE-CWA Local 475 Pension Plan alleges the specialty medication company sugarcoated two U.S. Food and Drug Administration investigations of its production of cancer drugs and infusion pumps and made misleading statements about the company's overall financial health.
These practices artificially bolstered the prices of...
Already a subscriber? Click here to login